Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ondansetron for ITM-Induced Pruritus in Children
NCT03262038Phase 4Terminated
- Sponsor
- University of Michigan
- Start
- Dec 2017
- Primary completion
- Aug 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in pruritus and postoperative nausea and vomiting (PONV) comparing Ondansetron IV with Placebo (2 arms). Primary endpoints: Incidence of Pruritus at 24 hours and Severity of Pruritus at 24 hours. Started Dec 2017; status: terminated.
02
Drugs
ondansetron
03
Conditions
prurituspostoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on NCT03262038.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03262038.